Category : Health Policy


UK-US Drug Deal: Tariffs Spared, NHS Costs Feared

A new UK-US medicines agreement exempts British drug exports from US tariffs but critics warn it could cost the NHS billions. The deal also expands patient access to life-extending treatments.

FDA Approves Eli Lilly's Foundayo Oral Weight-Loss Pill

The FDA has approved Eli Lilly's Foundayo, a once-daily oral GLP-1 weight-loss drug, marking the second such pill after Novo Nordisk's Wegovy. It offers flexible dosing and aims to improve accessibility for obesity treatment.

NHS Offers Weight-Loss Drug to 1.2M for Heart Health

NHS England expands access to semaglutide, offering weekly injections to 1.2 million overweight individuals at risk of heart attacks and strokes, following clinical trials showing cardiovascular benefits.

UK Government Screen Time Guidance for Under-Fives

New UK government advice recommends no more than one hour of daily screen time for children under five, with under-twos advised against solo screen use. Parents share their experiences and challenges.

Experts Warn Against Unregulated Injectable Peptides Online

Injectable peptides, promoted by influencers as a 'glow up potion' for various health issues, are not approved for human use and pose serious risks, warn medical experts. Unregulated online sales and unverified claims amplify dangers.

NHS Doctors Threaten 15th Strike Since 2023 Over Pay Issues

Resident doctors in the NHS are planning a six-day strike after Easter, marking their 15th walkout since 2023. The dispute centers on pay erosion, job security, and working hours, with tensions escalating despite recent government offers.

Eli Lilly Seeks NHS Price Rises for UK Investment Return

US pharmaceutical giant Eli Lilly, maker of Mounjaro, will only unpause its UK investments if ministers agree to regular NHS drug price increases and end a rebate scheme. Talks are ongoing with optimism for a summer agreement.

Page 5 of 26
Pickt mobile sticky banner — logo, tagline and CTA button